home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Access Rehab Equipment

SHARESHARESHARE
Access Rehabilitation Equipment is a trusted Australian supplier of an extensive range of equipment and related services to the healthcare industry. Continuing to build on its reputation as an established business with well-rounded equipment and aid expertise, Access Rehabilitation is providing solutions to maintain mobility and independence for people of limited abilities.
SHARESHARESHARE

RELATED NEWS


Their software, called S4ND, relies on deep learning techniques, coupled with more than 1,000 previously captured lung CT scans, to point out suspect lesions. The Central Florida team built a 3D convolutional neural network to power S4ND so that it doesn’t require any input from the user to produce the results. “We used the brain as a model to create our system,” said Rodney LaLonde, one of the researchers involved in the project. “You know how connections between neurons...
S4ND: SINGLE-SHOT SINGLE-SCALE LUNG NODULE DETECTION
READ MORE

The CEO of the UK’s medicine regulator has announced he will leave his post in September next year. With just months to go before the Brexit deadline, Dr. Ian Hudson, who has worked at the Medicines and Healthcare products Regulatory Agency (MHRA) for 17 years, said he was stepping down for ‘personal reasons’. Dr. Hudson said: “My reasons for stepping down are both personal and professional. I had always intended to reduce my total work commitment to enable me to pursue o...

READ MORE

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Functional (Non Ulcer) Dyspepsia (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Fu...

BUSINESSWIRE
READ MORE

The Medicines Manufacturing Industry Partnership (MMIP) is requesting government funds to help set up four new Centres of Excellence for medicines manufacturing across the UK, in line with wider plans to build on the exporting strengths of the UK's biopharma sector. According to the Partnership’s ‘Manufacturing Vision for UK Pharma’, the centres - for which the estimated set up cost is £140 million - would help plug gaps in the country’s capabilities in areas like diagnostics and packaging, adva...

READ MORE

Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) cleared the company's Investigational New Drug (IND) application to initiate a first-in-human study of GBR 310, a proposed biosimilar, which will assess its pharmacokinetics in comparison to XOLAIR® (omalizumab) in healthy adult volunteers between 18 – 65 years of age....

READ MORE

Scientists have developed and validated a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials. Scientists have teamed up to develop and validate a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials. The blood test measures a specific peptide in the blood to inform scientists, with 90 percent accuracy, if a patient has the very earliest s...
EUROPEAN PHARMACEUTICAL REVIEW
READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...